Chemotherapeutic and bone debridement Patient Reports February 11, 2012
Chemotherapeutic Side Effects Report #4955272-1
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, bone debridement, bone disorder, fistula
, fistula repair, osteonecrosis
, pain in jaw, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, ALKERAN, PREDNISONE, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4970172-9
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, bone debridement, bone disorder, fistula
, fistula repair, osteonecrosis
, pain in jaw, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, ALKERAN, PREDNISONE, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #5017726-1
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, bone debridement, bone disorder, fistula
, fistula repair, osteonecrosis
, pain in jaw, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, ALKERAN, PREDNISONE, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4666111-0
Chemotherapeutic side effect was reported by a Physician from on Dec 14, 2004. Female patient, 71 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess
, abscess jaw, bone debridement, incisional drainage, infection
, osteonecrosis
, primary sequestrum, tooth extraction, wound debridement. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA. Patient recovered.Chemotherapeutic Side Effects Report #4694718-3
Chemotherapeutic side effect was reported by a Consumer or non-health professional from on Apr 27, 2005. Female patient, 69 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: aseptic necrosis bone, bone debridement, surgery
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, FEMARA. Patient recovered.Chemotherapeutic Side Effects Report #4668719-5
Chemotherapeutic side effect was reported by a Health Professional from on Feb 24, 2005. Male patient, 58 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone debridement, osteomyelitis, osteonecrosis
, pain
, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI, ZOLEDRONIC ACID. Patient recovered.
Chemotherapeutic and bone debridement 